Recruiting
Phase 2

Dasatinib & Quercetin

Sponsor:

Washington University School of Medicine

Code:

NCT05838560

Conditions

Schizophrenia

Treatment Resistant Depression

Aging, Premature

Eligibility Criteria

Sex: All

Age: 50+

Healthy Volunteers: Not accepted

Interventions

Dasatinib

quercetin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by Washington University School of Medicine on 2025-04-02.